Recruiting Begins for Clinical Trial of EndoBarrier
Doctors across the United States are now recruiting hundreds of obese and diabetic patients for the U.S. pivotal clinical trial of EndoBarrier, the ENDO Trial, GI Dynamics announced yesterday. EndoBarrier is a thin, flexible, tube-shaped liner that forms a physical barrier between food and a portion of the intestine wall. The EndoBarrier alters the digestion [...]
Read the full article →REDUCE Clinical Trial Seeks Patients for Free Weight Loss Procedure
Researchers are currently recruiting patients to participate in the REDUCE Clinical Trial, a study sponsored by ReShape Medical to evaluate the ReShape Duo Weight Loss Balloon System. The ReShape Duo is a gastric dual-balloon designed to occupy space in the stomach to reduce food capacity so you feel full and satisfied with smaller amounts of [...]
Read the full article →EndoBarrier Therapy Gets FDA Approval for Clinical Trials
The FDA has given conditional approval to GI Dynamics to proceed with a pivotal clinical trial of the company’s EndoBarrier Therapy, a new type of treatment for patients with uncontrolled type 2 diabetes and obesity that does not involve medications or surgery. EndoBarrier is a thin, flexible, tube-shaped liner that acts as a physical barrier [...]
Read the full article →Weight Loss Intragastric Balloon Safe, Effective and Easy to Use
The intragastric dual balloon is safe, easy to use, and boosts weight loss, according to results of a small study recently published in Surgery for Obesity and Related Diseases. Intragastric balloons are designed to occupy space within the stomach to help patients feel full and satisfied with less food. The device can be left in [...]
Read the full article →abiliti System for Weight Loss Receives CE Mark Approval
The abiliti system by IntraPace has received CE Mark approval in the European Union as a treatment for obesity. While still considered an investigational device in the United States, this certification indicates that the weight loss treatment has met the requirements for commercial marketing in Europe. Unlike current methods of weight loss surgery which restrict [...]
Read the full article →TOGA Weight Loss Procedure A Top Ten Medical Innovation
The TOGA System, an endoscopic weight loss procedure for obesity, has been named one of the Top 10 Medical Innovations for 2011 by a panel of physicians and scientists at the Cleveland Clinic’s 2010 Medical Innovations Summit. This designation is awarded to up-and-coming technologies that will have “significant clinical impact and offer significant patients benefit [...]
Read the full article →Battling Obesity With Brain Surgery
Neurosurgeons from West Virginia University Health Sciences Center are targeting the brain rather than the stomach in one of the most innovative and radical new treatments for obesity. As highlighted by ABC’s Nightline last week, deep brain stimulation is being studied as a weight loss intervention for obesity in a three-year Food and Drug Administration [...]
Read the full article →EndoBarrier Demonstrates Significant Weight Loss in Advanced Trials
EndoBarrier non-surgical therapy continues to show positive results in advanced clinical trials, according to a press release issued this week by GI Dynamics. Following 12 months of use with the EndoBarrier, patients enrolled in the study lost an average of 20 percent of their body weight, or 49.5 pounds. In addition to significant weight loss, [...]
Read the full article →First Patient Fitted With ReShape Balloon Non-Surgical Weight Loss Device
ReShape Medical has announced that the first patient has been fitted with the ReShape Dual Balloons, thus launching the start of a U.S. Investigational Device Exemption (IDE) clinical study into the safety and effectiveness of this non-surgical device for weight loss. According to the company press release, the ReShape Balloons are designed to be a [...]
Read the full article →EndoBarrier Results in Rapid Resolution of Type 2 Diabetes
The EndoBarrier Gastrointestinal Liner continues to demonstrate considerable promise as a non-surgical therapy for type 2 diabetes and obesity. In clinical trials conducted to date, the results are similar to those seen with the Roux-en-Y gastric bypass procedure, but without surgery. According to a GI Dynamics press release dated November 11, 2009, patients who were [...]
Read the full article →
